U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
127998
Substance Class Protein
Created
by admin
on Sun Dec 18 09:07:56 UTC 2022
Edited
by admin
on Sun Dec 18 09:07:56 UTC 2022
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
2BJ58BX78W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KAPPA-TYPE OPIOID RECEPTOR
Common Name English
OPRK1
Common Name English
OPRK
Common Name English
K-OR-1
Common Name English
Code System Code Type Description
FDA UNII
2BJ58BX78W
Created by admin on Sun Dec 18 09:07:59 UTC 2022 , Edited by admin on Sun Dec 18 09:07:59 UTC 2022
PRIMARY
From To
1_131 1_210
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_25
N 1_39
Related Record Type Details
Structure of ALVIMOPAN
AGONIST -> TARGET
Structure of BW-942C
PARTIAL AGONIST->TARGET
Structure of BENZAMIDINE
INHIBITOR -> TARGET
Structure of NALTREXONE
INHIBITOR -> TARGET
Structure of NALDEMEDINE
INHIBITOR -> TARGET
Structure of SALVINORIN A
AGONIST -> TARGET
Ki
Structure of ATICAPRANT
INHIBITOR -> TARGET
Structure of NALDEMEDINE-CARBOXYLIC ACID
INHIBITOR -> TARGET
Structure of CMX-020
AGONIST -> TARGET
Structure of BTRX-335140
INHIBITOR -> TARGET
IC50
Structure of EKAP
RADIOLIGAND->TARGET
Ki
Structure of LY-2459989 F-18
RADIOLIGAND->TARGET
Structure of THIOBROMADOL
NON-INHIBITOR->OFF TARGET
Structure of CEBRANOPADOL
AGONIST -> TARGET
Structure of NALFURAFINE
AGONIST -> TARGET
Structure of DIFELIKEFALIN
AGONIST -> TARGET
Structure of ICI-199441
AGONIST -> TARGET
Structure of NALBUPHINE
AGONIST -> TARGET
Structure of CYX-6
INHIBITOR -> TARGET
Structure of Anrikefon
AGONIST -> TARGET
Structure of U-50488
AGONIST -> TARGET
Selective for the kappa receptor no mu activity.
Structure of FEKAP C-11
RADIOLIGAND->TARGET
Ki
Structure of PENTAZOCINE, (+)-
AGONIST -> TARGET
Structure of ASIMADOLINE
AGONIST -> TARGET
IC50
Structure of 3-METHYLTHIOFENTANYL
AGONIST -> TARGET
Structure of OXYCODONE
AGONIST -> TARGET
Structure of SAMIDORPHAN
PARTIAL AGONIST->TARGET
Structure of NALDEMEDINE 3-O-.BETA.-D-GLUCURONIDE
INHIBITOR -> TARGET
Structure of LY-2459989 C-11
RADIOLIGAND->TARGET
Structure of NALDEMEDINE 6-O-.BETA.-D-GLUCURONIDE
INHIBITOR -> TARGET
Structure of BUPRENORPHINE
INHIBITOR -> TARGET
BINDING
Ki
Structure of NOR-NALDEMEDINE
INHIBITOR -> TARGET
Structure of BUTORPHANOL
AGONIST -> TARGET
Structure of DERMORPHIN
NON-INHIBITOR->OFF TARGET
3-METHYLFENTANYL
AGONIST -> TARGET
Structure of CEBRANOPADOL
TARGET -> AGONIST
Structure of RB-64
AGONIST -> TARGET
Structure of LY-2459989
LIGAND->TARGET
Structure of FEKAP
TARGET->RADIOLIGAND
Ki
Structure of FEKAP C-11
TARGET->RADIOLIGAND
Ki
Structure of AT-076
INHIBITOR -> TARGET
ANTAGONIST
Structure of NORBINALTORPHIMINE
INHIBITOR -> TARGET
Structure of JDTIC
AGONIST -> TARGET
Structure of PENTAZOCINE
AGONIST -> TARGET
Structure of EKAP C-11
RADIOLIGAND->TARGET
Ki
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966